Industry University collaboration
PDF version

School of Pharmacy (UoN) and Universal Corporation are working together on a project funded by Federation of East African Pharmaceutical Manufacturers and GIZ. The project involves development of a generic Rufinamide (an orphan anti-epileptic drug) product for use in East Africa for the management of children with Lennox Gastaut Syndrome.

phase 1 of this project involves formulation development of generic rufinamide tablets and development and validation of methods of analysis and sclae up to industry level production.

 

AttachmentSize
Rufenamide-presentation-oluka-mod.ppt1.96 MB
Rufenamide-presentation.pdf2.4 MB